Benchmark raises its first-ever growth fund as part of $2B capital raise
Benchmark closed $2 billion across two new funds, including its first growth vehicle. The firm is loosening its early-stage-only model as AI rounds get bigger.
Intelligence analysis by GPT-5.4 Mini
Benchmark is moving beyond its long-running small-fund, early-stage discipline. After closing $2 billion across two new funds, it now has a $750 million early-stage fund and a $1.25 billion growth fund to back later-stage winners too.
Benchmark used to be like a picky club that only made small bets on new businesses. Now it has a much bigger wallet, so it can also help bigger, later-stage companies grow, especially in the pricey world of AI.
Analysis
A bigger Benchmark
Benchmark Capital has closed commitments for $2 billion across two new funds, according to the Wall Street Journal. That includes a $750 million early-stage fund and a $1.25 billion growth fund, which is a major departure for a firm that traditionally kept its funds at about $425 million or less.
For more than two decades, Benchmark built its reputation on a tight, selective model. It focused on young startups and typically took about a 20% stake in the companies it backed. The idea was to stay concentrated and aim for outsized returns rather than spread capital broadly.
The new structure suggests that model has become harder to maintain in today’s market, especially around AI. The article says Benchmark’s smaller fund sizes likely made it difficult for the firm to join the large, capital-intensive rounds common among foundation model companies. It has not backed Anthropic or OpenAI, and it also skipped several other heavily funded AI labs.
Benchmark has still been active in AI-adjacent bets. It led a $75 million round in Manus, an AI agent platform that reportedly reached $100 million in annual recurring revenue within eight months. But that investment became complicated when Chinese regulators blocked Meta’s planned acquisition of Manus in April, leaving Benchmark’s stake unresolved.
The firm’s latest fundraising also follows a strong outcome from Cerebras. Benchmark first led Cerebras’s Series A in 2016, later participated through an SPV in a pre-IPO round, and then saw the chipmaker’s IPO return $3.25 billion at the IPO price. The article says that windfall helped prompt the new growth fund.
What changes now
The growth fund is expected to make five to six large investments in existing portfolio companies and new startups. The early-stage fund also gives Benchmark more flexibility, including backing companies beyond Series A, such as recent Series B investments in Gumloop and Monaco.
The fundraise comes alongside partner turnover too. Benchmark has lost several partners over the past two years and added Everett Randle and Jack Altman as it rebuilds its bench for a more capital-heavy AI era.
Key points
- Benchmark closed commitments for $2 billion across two new funds.
- The firm is launching its first-ever growth fund, sized at $1.25 billion.
- A $750 million early-stage fund gives it more flexibility than its old Series A-only posture.
- Benchmark has missed some of the biggest capital-intensive AI labs, but has backed companies like Gumloop, Monaco, Manus, and Cerebras.
- A strong Cerebras IPO return appears to have helped justify the new growth vehicle.
If the new funds work as planned, Benchmark can support startups earlier and then keep backing the ones that grow into major winners. The growth fund also gives it room to make larger bets in companies it already knows, which could deepen those relationships.
A bigger, later-stage strategy can dilute the firm’s old advantage of extreme selectivity. The article also shows the risks of late-stage and AI investing: Benchmark’s Manus stake is still tied up after regulators blocked Meta’s acquisition, and larger AI rounds can be harder to exit cleanly.
